(Q64637968)

English

First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

An Open-label, Phase I, Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY 2010112, Given Once Daily by Subcutaneous Administration or by Continuous Intravenous Infusion, in Subjects With Castration-resistant Prostate Cancer (English)

0 references

0 references

0 references

2 November 2012

0 references

end time

18 July 2018

0 references